Clinical Trial Update: Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing etoposide-carboplatin alone or with Endostar in extensive-stage small cell lung cancer has completed. This update summarizes the trial r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Endostar (recombinant human endostatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED